204 related articles for article (PubMed ID: 29358899)
21. Oxidation of Cu, Zn-superoxide dismutase by the myeloperoxidase/hydrogen peroxide/chloride system: functional and structural effects.
Auchère F; Capeillère-Blandin C
Free Radic Res; 2002 Nov; 36(11):1185-98. PubMed ID: 12592671
[TBL] [Abstract][Full Text] [Related]
22. Effects of hypochlorous acid on unsaturated phosphatidylcholines.
Arnhold J; Osipov AN; Spalteholz H; Panasenko OM; Schiller J
Free Radic Biol Med; 2001 Nov; 31(9):1111-9. PubMed ID: 11677044
[TBL] [Abstract][Full Text] [Related]
23. Al amyloidosis.
Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
[TBL] [Abstract][Full Text] [Related]
24. Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains.
Davern S; Murphy CL; O'Neill H; Wall JS; Weiss DT; Solomon A
Biochim Biophys Acta; 2011 Jan; 1812(1):32-40. PubMed ID: 20692337
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.
Lavatelli F; Mazzini G; Ricagno S; Iavarone F; Rognoni P; Milani P; Nuvolone M; Swuec P; Caminito S; Tasaki M; Chaves-Sanjuan A; Urbani A; Merlini G; Palladini G
J Biol Chem; 2020 Dec; 295(49):16572-16584. PubMed ID: 32952127
[TBL] [Abstract][Full Text] [Related]
26. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
Ramirez-Alvarado M; Barnidge DR; Murray DL; Dispenzieri A; Marin-Argany M; Dick CJ; Cooper SA; Nasr SH; Ward CJ; Dasari S; Jiménez-Zepeda VH; Leung N
Am J Hematol; 2017 Jun; 92(6):536-541. PubMed ID: 28295502
[TBL] [Abstract][Full Text] [Related]
27. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
[TBL] [Abstract][Full Text] [Related]
28. Producing amyloid fibrils in vitro: A tool for studying AL amyloidosis.
Sizova DV; Raiker S; Lakheram D; Rao V; Proffitt A; Jmeian Y; Voegtli W; Batonick M
Biochem Biophys Rep; 2023 Jul; 34():101442. PubMed ID: 36875796
[TBL] [Abstract][Full Text] [Related]
29. Influence of chloride on modification of unsaturated phosphatidylcholines by the myeloperoxidase/hydrogen peroxide/bromide system.
Panasenko OM; Vakhrusheva T; Tretyakov V; Spalteholz H; Arnhold J
Chem Phys Lipids; 2007; 149(1-2):40-51. PubMed ID: 17604010
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
[TBL] [Abstract][Full Text] [Related]
31. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
32. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
[TBL] [Abstract][Full Text] [Related]
33. Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.
Enqvist S; Sletten K; Stevens FJ; Hellman U; Westermark P
PLoS One; 2007 Oct; 2(10):e981. PubMed ID: 17912358
[TBL] [Abstract][Full Text] [Related]
34. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
35. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
Morgan GJ; Kelly JW
J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
[TBL] [Abstract][Full Text] [Related]
36. Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
Arendt BK; Ramirez-Alvarado M; Sikkink LA; Keats JJ; Ahmann GJ; Dispenzieri A; Fonseca R; Ketterling RP; Knudson RA; Mulvihill EM; Tschumper RC; Wu X; Zeldenrust SR; Jelinek DF
Blood; 2008 Sep; 112(5):1931-41. PubMed ID: 18567838
[TBL] [Abstract][Full Text] [Related]
37. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.
Brenner DA; Jain M; Pimentel DR; Wang B; Connors LH; Skinner M; Apstein CS; Liao R
Circ Res; 2004 Apr; 94(8):1008-10. PubMed ID: 15044325
[TBL] [Abstract][Full Text] [Related]
38. A functional assay to identify amyloidogenic light chains.
Martin EB; Williams AD; Heidel RE; Foster JS; Lands RH; Kennel SJ; Wall JS
Amyloid; 2018 Jun; 25(2):93-100. PubMed ID: 29571269
[TBL] [Abstract][Full Text] [Related]
39. Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation.
Raftery MJ; Yang Z; Valenzuela SM; Geczy CL
J Biol Chem; 2001 Sep; 276(36):33393-401. PubMed ID: 11445563
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
